A complete weight loss and body transformation plan medication, body sculpting, and skin tightening in one coordinated program.
Semaglutide or Mounjaro (tirzepatide) your choice based on your provider's recommendation. Weekly injections, clinically proven.
4 EvolveX body sculpting sessions per month, included in the program. Sculpts and tightens as you lose weight.
Every patient has a licensed Aviva provider managing their program dosing, check-ins, and support from start to finish.
Medical weight loss at Aviva Medical Spa is not a subscription service that ships medication to your door. It’s a supervised 3-month program that combines FDA-approved GLP-1 medication your choice of semaglutide or Mounjaro (tirzepatide) with 12 EvolveX body sculpting sessions and 3 Morpheus8 treatments, designed around the reality of what happens to the body during significant weight loss. GLP-1 medications work by mimicking the hormones that regulate appetite and blood sugar, enabling the kind of sustained caloric reduction that produces real, measurable weight loss. But as the weight comes off, the body changes in ways that medication alone doesn’t address skin laxity develops, body composition shifts, and facial volume can change. Aviva’s program is built around this. EvolveX actively sculpts and tightens your body as fat reduces. Morpheus8 addresses skin quality changes before they become a concern. You finish the program with the weight loss and the physical transformation to match supported by a licensed medical provider who manages your dosing, monitors your progress, and adjusts your plan throughout.
Included: 4 weekly injections per month (12 total)
What It Does in the Program?
GLP-1 medication for appetite regulation and sustained weight loss. In-office administration or self-administered at home. Provider manages dosing and titration throughout.
GLP-1 MEDICATION · WEEKLY INJECTION · YOUR CHOICE
Semaglutide (Ozempic® / Wegovy®) and Mounjaro (tirzepatide / Zepbound®) are both FDA-approved GLP-1 medications available in the Aviva program. Mounjaro is the newer dual GLP-1 + GIP receptor agonist with higher average clinical results (22% body weight loss vs. 15% for semaglutide). Your Aviva provider will recommend which is right for your health history at consultation. Both are offered in-office or for home self-administration.
→ Full details at semaglutide and mounjaro
Included:
4 sessions per month (12 total) · 30–60 min each · no downtime
What It Does in the Program?
RF and EMS body contouring to sculpt, tighten, and tone as fat reduces. Prevents the loose skin and deflated appearance common after rapid weight loss. No downtime.
BODY SCULPTING + SKIN TIGHTENING + MUSCLE STIMULATION
EvolveX uses radiofrequency energy, electrical muscle stimulation, and vacuum technology to contour, tighten, and tone the body simultaneously. 4 sessions per month means your body is being actively sculpted throughout your entire weight loss journey not left to settle on its own. No anesthesia, no downtime, no recovery.
Included:
1 session per month (3 total)
What It Does in the Program?
RF microneedling for skin tightening. Body application for abdominal, arm, or thigh laxity. Face application for patients experiencing facial volume changes during weight loss.
RF MICRONEEDLING · SKIN TIGHTENING · BODY OR FACE
Morpheus8 RF microneedling stimulates collagen and tightens skin from within applied to the body for areas of laxity (abdomen, arms, thighs) or to the face for patients experiencing volume and skin quality changes during weight loss. One session per month, scheduled at strategic points in your program. Results develop progressively over 3 months.
BMI ≥ 27 with a weight-related health condition
BMI ≥ 30 regardless of other conditions
Difficulty losing weight through diet and exercise alone
Pre-diabetic or type 2 diabetic patients (under provider review)
Patients wanting combined weight loss + aesthetic body results
Patients who have regained weight and want a medically supported reset
Pregnancy or breastfeeding
Personal or family history of medullary thyroid cancer
History of pancreatitis (provider review required)
Certain medications reviewed at consultation
Significant GLP-1 weight loss can accelerate facial volume loss a well-documented side effect sometimes called "Ozempic face." Sculptra collagen biostimulation restores the facial structure that changes with significant weight loss, gradually and naturally.
After the 3-month program, patients who want continued body contouring can add EvolveX sessions as a maintenance protocol. Particularly useful for patients who continue losing weight beyond the initial program or want to refine specific areas.
Peptide therapy supports metabolism, muscle preservation, and recovery as an ongoing complement to your results after the GLP-1 program. Your provider will assess which peptides are appropriate for your goals.
The 3-month program includes: semaglutide or Mounjaro (tirzepatide) 4 weekly injections per month, 12 EvolveX body sculpting sessions (4 per month), and 3 Morpheus8 Body or Face sessions (1 per month). You choose between in-office injection administration or home self-administration. A consultation is included before enrollment.
Both are FDA-approved GLP-1 medications available in the Aviva program. Mounjaro (tirzepatide) is a newer dual-agonist that activates both GLP-1 and GIP receptors, showing higher average clinical weight loss approximately 22% vs. 15% for semaglutide. Semaglutide has a longer established track record. Your Aviva provider will recommend the right option based on your medical history at consultation.
Significant weight loss changes the body in ways that medication alone doesn’t address skin laxity develops, body composition shifts, and facial volume can change. EvolveX actively sculpts and tightens the body as fat reduces. Morpheus8 addresses the skin quality changes that accompany weight loss on the body and face. They’re included because a complete transformation requires more than a prescription.
Ozempic face refers to the facial volume loss and hollowing that can occur alongside significant GLP-1 weight loss. It’s a real and common side effect. Morpheus8 is included in the program to address skin quality changes, and Sculptra collagen biostimulation is available as a complementary treatment for patients experiencing more significant facial volume loss during or after the program.
Yes. Both semaglutide and Mounjaro come in pre-filled pens for once-weekly subcutaneous injection. Aviva offers in-office administration at no extra charge, or you can self-administer at home after a technique demonstration. Most patients transition to home administration after the first session.
Your Aviva provider discusses a transition plan before your program ends including options for continuing medication at a maintenance dose, dose reduction protocols, and ongoing EvolveX or Morpheus8 sessions. Peptide therapy is also available as long-term metabolic support. The goal is a sustainable result, not just a 3-month outcome.
The GLP-1 market is full of services that ship you medication with minimal oversight. At Aviva Medical Spa in Miami’s Design District, every patient in our program has a licensed medical provider managing their medication, monitoring their progress, and adjusting the plan as needed. And unlike telehealth services, Aviva’s program includes the body sculpting and skin tightening that make the physical transformation complete. The EvolveX and Morpheus8 sessions aren’t add-ons they’re part of the program because they’re part of the result. If you’re going to go through three months of medical weight loss, you deserve to come out the other side looking as good as you feel.
Your Glow Starts Here
Your Glow Starts Here
